| Tag | Content |
|---|
EnhancerAtlas ID | HS093-12492 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr17:17307000-17307850 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr17:17307641-17307659 | GGAGGGAAGGCAGGATGC | + | 6.39 | | EWSR1-FLI1 | MA0149.1 | chr17:17307637-17307655 | GGGAGGAGGGAAGGCAGG | + | 7.5 | | PLAG1 | MA0163.1 | chr17:17307393-17307407 | GGGGGCCTAGGGGA | + | 6.1 | | ZNF263 | MA0528.1 | chr17:17307638-17307659 | GGAGGAGGGAAGGCAGGATGC | + | 6.04 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_25519 | chr17:17300976-17312445 | DND41 | | SE_65490 | chr17:17306179-17308335 | Pancreatic_islets |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I017403 | chr17 | 17306331 | 17308807 |
|
Enhancer Sequence | GTCTGCAGGC AGGTGTGGAG GGCAGGTGCC TGGCTGGTCT GGTGGCCGTC CTTTGATTAC 60
TTTTCAGAAG CAGCCGGAAA ATAAGGCTCA AGTGCCCAGA ATAGAAAGCC AGGCCGTCCA 120
AACATAGGTT TAAAAAATAT AACCGGGAAA AATCAACTTC CTTATGTTCA CACTCGACCT 180
CAGGTGTATT CATGGGGAAA CGGCGAGAGG TCTGGAGGAT GTTTGCAGCT GCTGTGGGTG 240
GTGGTGGGCA GGAAGCCCTC CCCACCACCG CTCTGCCTGT GCGCCCGATC TGCCCGCCGT 300
GGGGCCCAGA CACACTTCCT CCTCTCCCTC TGCGCTCTGC TCCGAGGGCA ATTTGGCATC 360
TGCCGCCTTC AATTAACATT GCAGACTGGA AGTGGGGGCC TAGGGGAAGG AGGTGGGCCG 420
CAGCGGAGAA AAACAAGCCC ACTGTGTTGA CAGCTGGGCA CACCACCTGC TCCAGTGTGG 480
CAGGGAAGTT GAGGACCGCA AAGCCAGGAG GGGGTGAGGG AAGGCTGTTG CACACACTGG 540
GCCTCTGTGC CCCCCTCACC GGTTGCACCC CCAGATGCAG GCTCTGTCCC AGTCCCTGTG 600
CCAGGACTGG CTTGAACAGA CCCCTCAGCC CTCTGATGGG AGGAGGGAAG GCAGGATGCA 660
CCGAGGTGGG AGTGTTTCTC CAGCCCTCTC TCTGCCAGGC TGAGTCTTGC TGGTTTCCCT 720
TGATGGTGCA CACCAAGGGA TCCTTCACTG AACTCCCTGC AGTTACCGTG GCAGGCAGGC 780
TTTTTCCTGC TGCAACACTG GCTGCTACCC CAGATAGTGC CTCGGTGGGT GACTGCGTAA 840
GGAGAGCAGC 850
|
